Smallpox as a biological weapon: Medical and public health management

JAMA

Volumn 281, Issue 22, 1999, Pages 2127-2137

  Henderson, Donald A ^a,b   Inglesby, Thomas V ^a,c   Bartlett, John G ^a,c   Ascher, Michael S ^d   Eitzen, Edward ^e   Jahrling, Peter B ^e   Hauer, Jerome ^f   Layton, Marcelle ^g   McDade, Joseph ^h   Osterholm, Michael T ⁱ   O'Toole, Tara ^a,b   Parker, Gerald ^e   Perl, Trish ^a,c   Russell, Philip K ^a,b   Tonat, Kevin ^j  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c School of Medicine   (United States)

^d California Department of Health   (United States)

^e UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^f Office of Emergency Management   (United States)

^g New York City Health Department   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ MINNESOTA DEPARTMENT OF HEALTH   (United States)

^j U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

ARTICLE; BIOLOGICAL WARFARE; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; PUBLIC HEALTH; SMALLPOX; VIRUS ISOLATION;

EID: 0033538314     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.22.2127     Document Type: Article

References (51)

1. Inglesby TV, Henderson DA, Bartlett JC, et al. Anthrax as a biological weapon : medical and public health management. JAMA. 1999;281:1735-1745.
2. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and Its Eradication. Geneva, Switzerland: World Health Organization; 1988:1460.
3. Steam EW, Stearn AE. The Effect of Smallpox on the Destiny of the Amerindian. Boston, Mass: Bruce Humphries; 1945.
4. Hopkins DR. Princes and Peasants. Chicago, III: University of Chicago Press; 1983.
5. World Health Organization. The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradication. Geneva, Switzerland: World Health Organization; 1980.
6. Breman JG, Henderson DA. Poxvirus dilemmas: monkeypox, smallpox and biological terrorism. N Engl J Med. 1998;339:556-559.
7. Institute of Medicine. Assessment of Future Scientific Need for Live Variola Virus. Washington, DC: National Academy Press; 1999.
8. Alibek K. Biohazard. New York, NY: Random House Inc; 1999.
9. Harper GJ. Airborne micro-organisms: survival test with four viruses. J Hyg. 1961;59:479-486.
10. Wehrle PF, Posch J, Richter KH, Henderson DA. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Organ. 1970; 43:669-679.
11. Chapin CV, Smith J. Permanency of the mild type of smallpox. J Prev Med. 1932;1:1-29.
12. Esposito JJ, Knight JC. Orthopox DNA: a comparison of restriction profiles and maps. Virology. 1985; 143:230-251.
13. Chapin CV. Variation in the type of infectious disease as shown by the history of smallpox in the United States, 1895-1912. J Infect Dis. 1913;13:171-196.
14. Anders W, Sosch J. Die Pockenausbrucke 1961/61 in Nordrhein-Westfalen. Bundesgesundheitsblatt. 1962;17:265-269.
15. Dixon CW. Smallpox. London, England: J & A Churchill Ltd; 1962:1460.
16. Joarder AK, Tarantola D, Tulloch J. The Eradication of Smallpox From Bangladesh, New Delhi. Geneva, Switzerland: WHO Regional Publications; 1980.
17. Mack TM. Smallpox in Europe, 1950-71. J Infect Dis. 1972;125:161-169.
18. Mack TM, Thomas DB, Khan MM. Epidemiology of smallpox in West Pakistan, II: determinants of intravillage spread other than acquired immunity. Am J Epidemiol. 1972;95:157-168.
19. Rao AR. Infected Inanimate Objects (Fomites) and Their Role in Transmission of Smallpox. Geneva, Switzerland: World Health Organization; 1972. WHO/ SE/72.40.
20. Fenner F, Wittek R, Dumbell KR. The Orthopoxviruses. San Diego, Calif: Academic Press; 1988:432.
21. Jezek Z, Fenner F. Human Monkeypox. Basel, Switzerland: S Karger; 1988.
22. Sarkar JK, Mitra AC, Mukherjee MK, De SK. Virus excretion in smallpox, 2: excretion in the throat of household contacts. Bull World Health Organ. 1973; 48:523-527.
23. Rao AR. Smallpox. Bombay, India: Kothari Book Depot; 1972.
24. Downie AW, McCarthy K. The antibody response in man following infection with viruses of the pox group, III: antibody response in smallpox. J Hyg. 1958;56:479-487.
25. Marsden JP. Variola minor: a personal analysis of 13,686 cases. Bull Hyg. 1948;23:735-746.
26. Redfield RR, Wright CD, James WD, Jones ST, Brown C, Burke D. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV). N Engl J Med. 1987;316:673-676.
27. Esposito JJ, Massung RF. Poxvirus infections in humans. In: Murray PR, Tenover F, Baron EJ, eds. Clinical Microbiology. Washington, DC: American Society of Microbiology; 1995:1131-1138.
28. Knight JC, Massung RF, Esposito JJ. Polymerase chain reaction identification of smallpox virus. In: PCR-Protocols for Diagnosis of Human and Animal Viral Disease. Heidelberg, Germany: Springer-Verlag; 1995: 297-302.
29. Ropp SL, Knight JC, Massung RF, Esposito JJ. PCR strategy for identification and differentiation of smallpox and other orthopoxviruses. J Clin Microbiol. 1995; 33:2069-2076.
30. US Bureau of the Census. Resident Population of the United States: Estimates, by Age and Sex. Washington, DC: US Bureau of the Census; 1998.
31. El-Ad R, Roth Y, Winder A. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis. 1990;161:446-448.
32. World Health Organization. Smallpox vaccine and seed virus survey. Working document for the meeting of the WHO Ad Hoc Expert Committee on Orthopoxvirus Infections; January 14-15, 1999; Geneva, Switzerland.
33. Sharp JCM, Fletcher WB. Experience of antivaccinia immunoglobulin in the United Kingdom. Lancet. 1973;1:656-659.
34. Kempe CH. Studies on smallpox and complications of smallpox vaccination. Pediatrics. 1960;26: 176-189.
35. Koplan J, Monsur KA, Foster SO, et al. Treatment of variola major with adenine arabinoside. J Infect Dis. 1975;131:34-39.
36. Monsur KA, Hossain MS, Huq F, Rahaman MM, Haque MQ. Treatment of variola major with cytosine arabinoside. J Infect Dis. 1975; 131:40-43.
37. Lalezari JP, Staagg RJ, Kuppermann BD, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial. Ann Intern Med. 1997;126:257-263.
38. O'Toole T. Smallpox: a case history. Emerg Infect Dis. In press.
39. Dixon CW. Smallpox in Tripolitania, 1946: an epidemiological and clinical study of 500 cases, including trials of penicillin treatment. J Hyg. 1948;46:351-377.
40. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine recommendations of the immunization practices advisory committee. MMWR Morb Mortal Wkly Rep. 1990;40(RR-14):445-448.
41. World Health Organization. WHO Expert Committee on Smallpox Eradication. Geneva, Switzerland: World Health Organization; 1972:493. WHO technical report series.
42. Henderson DA, Arita I, Shafa E. Studies of the bifurcated needle and recommendations for its use. Geneva, Switzerland: World Health Organization; 1972. WHO Smallpox Eradications Paper SE/72.5.
43. McIntosh K, Cherry JD, Benenson AS. Standard percutaneous (smallpox) revaccination of children who received primary percutaneous vaccination. J InfectDis. 1990;161:445-448.
44. Wyeth Smallpox Vaccine [package insert]. Lancaster, Pa: Wyeth Laboratories Inc; 1988.
45. Lane JM, Ruben FL, Neff JM, Millar JD. Complicatons of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med. 1969;281:1201-1208.
46. Goldstein VA, Neff JM, Lande JM, Koplan J. Smallpox vaccination reactions, prophylaxis and therapy of complications. Pediatrics. 1975;55:342-347.
47. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee. MMWR Morb Mortal Wk;y Rep. 1991;40:1-10.
48. Huq F. Effect of temperature and relative humidity on variola virus in crusts. Bull World Health Organ. 1976;54:710-712.
49. Wolff HL, Croon JJ. The survival of smallpox virus (variola minor) in natural circumstances. Bull World Health Organ. 1968;38:492-493.
50. Hashizume S, Yoshizawa H, Morita M, Suzuki K. Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. In: Quinnan CV, ed. Vaccine Virus as Vectors for Vaccine Antigens. Amsterdam, the Netherlands: Elsevier Science Publishing; 1985:87-99.
51. Hirayama M. Smallpox vaccination in Japan. In: Fukumi H, ed. The Vaccination: Theory and Practice. Tokyo: International Medical Foundation of Japan; 1975:113-124.